About Amprion

๐—š๐—ฟ๐—ผ๐˜‚๐—ป๐—ฑ๐—ฏ๐—ฟ๐—ฒ๐—ฎ๐—ธ๐—ถ๐—ป๐—ด ๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—ณ๐—ผ๐—ฟ ๐—”๐—น๐˜‡๐—ต๐—ฒ๐—ถ๐—บ๐—ฒ๐—ฟ'๐˜€, ๐—ฃ๐—ฎ๐—ฟ๐—ธ๐—ถ๐—ป๐˜€๐—ผ๐—ป'๐˜€, ๐—ฎ๐—ป๐—ฑ ๐—Ÿ๐—ฒ๐˜„๐˜† ๐—•๐—ผ๐—ฑ๐˜† ๐——๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐—ถ๐—ฎ. ๐—ช๐—ฒ detect ๐˜๐—ต๐—ฒ misfolded proteins ๐—ฏ๐—ถ๐—ผ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐—ฟ๐˜€ ๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ๐˜€๐—ฒ ๐—ฏ๐—ฟ๐—ฎ๐—ถ๐—ป ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€.

Amprion pioneers Testing for diseases associated with mis-folded proteins. Detection Testingโ„  for Alzheimerโ€™s and Parkinsonโ€™s. For the first time in history, our proprietary molecular-based diagnostic technology tracks ththat drive Alzheimerโ€™s and Parkinsonโ€™s prior to any clinical.

Early diagnosis of Alzheimerโ€™s and Parkinsonโ€™s empowers us to find a cure to stop these diseases on their tracks.
Alzheimerโ€™s and Parkinsonโ€™s are two related diseases on a spectrum: https://www.ampriondx.com


== About FDA Breakthrough Device Designation ===
FDAโ€™s Breakthrough Devices Program is designed to speed up development, assessment and review of medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.

== How Amprion Works ===
Amprionโ€™s breakthrough early testing for Alzheimer's and Parkinson's detects mis-folded proteins or, biomarkers, using spinal fluid (CSF).

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
535 Mission St. #14th Floor, San Francisco, CA 94105, US
description icon
Founded
2007
description icon
Keywords
Biotech, Healthcare, Neurology, Personalized Medicine, Alzheimer's Disease, Parkinson's Disease, Aging, Prions, Brain Health, Neurodegenerative Disease, Alpha-Synuclein, Tau, Apoe4, Fda Breakthrough Device, Abeta, Blood Test For Parkinson's, Dementia With Lewy Bodies

Frequently Asked Questions about Amprion

Who is the CEO of Amprion?

Russ Lebovitz is the CEO of Amprion. To contact Russ Lebovitz email at [email protected]. Or you may call +16504851460

Who are the decision makers in Amprion?

The decision makers in Amprion are Armin Braun, Gerald Kaendler, Gerald Kaendler, etc. Click to Find Amprion decision makers emails.

How can I contact Amprion for inquiries about their testing services?

You can reach Amprion by visiting their website and using the 'Contact Us' form. Alternatively, you can call their main office number listed on the site for direct inquiries regarding their testing services for Alzheimerโ€™s, Parkinsonโ€™s, and Lewy Body Dementia.

Is there a staff directory available for Amprion?

Amprion does not publicly provide a detailed staff directory on their website. However, you can contact their customer service for specific inquiries regarding their team members or to get in touch with a particular department.

What types of diseases does Amprion specialize in testing?

Amprion specializes in testing for neurodegenerative diseases associated with misfolded proteins, including Alzheimerโ€™s, Parkinsonโ€™s, and Dementia with Lewy Bodies. Their innovative Detection Testingโ„  aims to identify specific biomarkers linked to these conditions.

Can I get information about Amprion's services for healthcare providers?

Yes, healthcare providers can find detailed information about Amprion's services on their website. They offer insights into their testing methodologies, clinical applications, and how to integrate these tests into patient care for neurodegenerative diseases.

What industries does Amprion support with its testing solutions?

Amprion primarily supports the biotech and healthcare industries, focusing on neurology and personalized medicine. Their innovative testing solutions are designed for researchers, clinicians, and healthcare providers working with neurodegenerative diseases.

How can I stay updated on Amprion's latest developments and services?

To stay informed about Amprion's latest developments, you can subscribe to their newsletter through their website. Additionally, following their social media channels will provide updates on new services, research findings, and industry news.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more